Nomination by the Prix Galien Foundation recognizes the AeroPace® System, the first FDA-approved diaphragm neurostimulation therapy to help critically ill patients breathe on their own again EXTON, Pa., Aug. 19, 2026 (GLOBE NEWSWIRE) — Lungpacer Medical Inc. today announced that its AeroPace System has been nominated for the 2026 Prix Galien USA Award for Best […]
VANCOUVER, British Columbia, Aug. 19, 2026 (GLOBE NEWSWIRE) — Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is…
New findings further call into question scientific judgment of current health leaders in the Trump administration A French researcher whose work was praised by Donald Trump and Dr Mehmet Oz during the…
Chinese biotech Biokin said its EGFRxHER3 bispecific antibody-drug conjugate passed a late-stage China trial in a genetically-defined form of lung cancer, buoying optimism for a similar global study…
